Exactus, Inc. announces name C
GOLDEN, CO / ACCESSWIRE / October 28, 2021 / Exactus, Inc. (OTCQB: EXDID), (the “Company”), a premium, cGMP-certified, vertically integrated CBD and cannabinoid company, today announced that the Financial Industry Regulatory Authority, Inc. (“ FINRA ”) approved the name change of the Company. to “Panacea Life Sciences Holdings, Inc.” (from Exactus, Inc.). This corporate action will come into effect at the opening of trading on October 28, 2021. The new CUSIP number for the ordinary share will be 69810P109. The Company also carried out a reverse stock split of 1 to 28 shares.
As part of the name change, a temporary symbol, EXDID has been assigned to the company which will become PLSH twenty working days from October 28, 2021.
These changes follow the Company’s announcement on June 30, 2021 of the successful completion of an exchange transaction with Exactus, Inc. whereby Panacea Life Sciences, Inc. became a wholly-owned subsidiary. of the society.
Leslie Buttorff, CEO and Executive Chairman of Panacea, said: “The name and ticker change is essential for the company as we look forward to publicizing the foundation of the PANA brand that we have built as a leader in the research on cannabinoids and natural alternative medicine and our future. long-term shareholder value creation objectives. “
Exactus, Inc. (OTCQB: EXDID) (the “Company”), acquired Panacea Life Sciences, Inc. on June 30, 2021. Panacea, which was founded by Leslie Buttorff in 2017 as a woman-owned business, raised $ 20 million dollars in initial investments. In 2019, these were followed by a $ 14 million investment of 22sd Century Group, Inc. (NYSE American: XXII), a leading plant biotechnology company focused on reducing nicotine in tobacco plants and using its expertise in genetic engineering of hemp plants to alter the levels of cannabinoids used in the manufacture of CBD, CBG and CBN.
Panacea Life Sciences, Inc. is a leader in the production of legal THC-based hemp-derived products for consumers and pets that operates a 51,000 square foot cGMP certified facility in Golden, Colorado and the PANA Botanicals farm in western Colorado , with extraction, fabrication, fabrication, testing and accomplishment. Panacea produces capsules, gummies, tinctures, sublingual tablets, cosmetics and other topical products for purchase online (www.panacealife.com) and in stores as well as in smart vending machines being rolled out. at national scale.
If you would like more information on this topic or to learn more about Panacea and its products or our land-to-brand practices, please visit panacealife.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “may”, “estimate”, “continue”, “anticipate”, “intend”, “Should,” “,,”, “” We have based these forward-looking statements in large part on our current expectations and projections regarding future events and financial trends that we believe could affect our financial condition, results of operations , our business strategy and our financial needs. Any forward-looking statements we make here speak only as of the date on which they are made. Factors or events that could cause our actual results to vary may occur from time to time, and we cannot predict all of them. We assume no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.
THE SOURCE: Exactus inc.
See the source version on accesswire.com: